Guideline for the investigation and management of eosinophilia

                         A British Society for Haematology Guideline

  Nauman M. Butt,1 Jonathan Lambert,2 Sahra Ali,3 Philip A. Beer,4 Nicholas C.P.
Cross,5 Andrew Duncombe,6 Joanne Ewing,7 Claire N. Harrison,8 Steven Knapper,9

     Donal McLornan,10 Adam J. Mead,11 Deepti Radia,8 and Barbara J. Bain.12
                Writing group: British Society for Haematology Guidelines

 1Royal Liverpool and Broadgreen University Teaching Hospitals NHS Trust, Liverpool,
  2University College London Hospitals NHS Foundation Trust, London 3Hull and East
 Yorkshire Hospitals NHS Trust, 4Wellcome Trust Sanger Institute, Cambridge, 5Faculty
  of Medicine, University of Southampton, Southampton, 6Department of Haematology,
  University Hospital Southampton, Southampton, 7Heart of England NHS Foundation

Trust, Birmingham, 8Guy’s and St Thomas’ NHS Foundation Trust, London, 9Division of
  Cancer & Genetics, School of Medicine, Cardiff University, Cardiff., 10King's College
     Hospital NHS Foundation Trust, London, 11MRC Molecular Haematology Unit,

Weatherall Institute of Molecular Medicine, University of Oxford and BRC Blood Theme,
    NIHR Oxford Biomedical Centre, Oxford, UK and 12Imperial College London, St
                                    Mary’s Hospital, London, UK

Keywords: eosinophilia, hypereosinophilia, eosinophilic leukaemia, HES

Correspondence: BSH Administrator, British Society for Haematology, 100 White
Lion Street, London N1 9PF UK
Email: bshguidelines@b-s-h.org.uk

                                                     1